We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OGN market cap is 4.02B. The company's latest EPS is USD 3.9722 and P/E is 3.92.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.52B | 1.6B | 1.62B | 1.61B | 1.58B |
| Operating Income | 232M | 254M | 376M | 371M | 339M |
| Net Income | 58M | 546M | 201M | 195M | 359M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.53B | 8.1B | 6.3B | 6.17B | 6.26B |
| Operating Income | 3.55B | 2.71B | 1.81B | 1.57B | 1.26B |
| Net Income | 3.22B | 2.16B | 1.35B | 917M | 1.02B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.01B | 12.06B | 11.89B | 12.15B | 12.75B |
| Total Liabilities | 11.6B | 12.13B | 11.84B | 12.01B | 12.26B |
| Total Equity | -589M | -70M | 48M | 144M | 493M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.55B | 9.92B | 10.68B | 10.96B | 12.06B |
| Total Liabilities | 3.51B | 4.43B | 12.19B | 11.85B | 12.13B |
| Total Equity | 7.04B | 5.49B | -1.51B | -892M | -70M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 402M | 799M | 76M | 408M | 549M |
| Investing | -179M | -260M | -96M | -142M | -217M |
| Financing | -492M | -569M | -74M | -208M | -286M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.77B | 2.19B | 2.46B | 858M | 799M |
| Investing | -102M | -258M | -481M | -420M | -260M |
| Financing | -2.62B | -2.18B | -1.33B | -433M | -569M |
| Market Cap | 4.02B |
| Price to Earnings Ratio | 3.92 |
| Price to Sales Ratio | 0.64 |
| Price to Cash Ratio | 5.79 |
| Price to Book Ratio | -57.32 |
| Dividend Yield | 7.17% |
| Shares Outstanding | 257.54M |
| Average Volume (1 week) | 4.34M |
| Average Volume (1 Month) | 2.87M |
| 52 Week Change | 41.78% |
| 52 Week High | 23.10 |
| 52 Week Low | 10.835 |
| Spread (Intraday) | 0.07 (0.45%) |
| Company Name | Organon and Co |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.organon.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
